US Activist Hedge Fund Institutional SEC 13D 13G — September 08, 2026

08-09-2026

PAMT CORP filed Amendment No. 17 to its Schedule 13D, disclosing that Matthew T. Moroun sold 3,268,000 shares (approximately 15.6% of outstanding shares) to the 2020 Lindsay Moroun Trust on September 3, 2026, for $31,226,000 ($9.555 per share). The sale was for ownership succession purposes and was funded by an interest-bearing promissory note. Following the transaction, the Moroun Grantor Trust no longer beneficially owns any shares, while the 2020 Lindsay Moroun Trust increased its stake to 74.9% and Frederick P. Calderone to 76.5%.

• · The sale was funded by an interest-bearing promissory note from the 2020 Lindsay Moroun Trust to Matthew T. Moroun for $31,226,000, payable in monthly installments through September 2, 2035.
• · The Moroun Grantor Trust ceased to be a beneficial owner of more than 5.0% of outstanding shares on August 18, 2026.
• · Matthew J. Moroun received 1,453 shares of Common Stock on May 8, 2026, in lieu of cash for a portion of the annual retainer for non-employee directors.
• · The per share price of $9.555 was determined by an independent third party using the average of high and low prices on Nasdaq on September 3, 2026, adjusted for a block-trade discount.
• · The transaction was structured to be at fair market value for federal gift tax purposes, with an independent appraisal from Stout Risius Ross, LLC.

08-09-2026

Bryan Ganz, former CEO of Byrna Technologies, filed an amended Schedule 13D disclosing aggregate beneficial ownership of 2,296,635 shares (9.6% of outstanding common stock) as of September 8, 2026. The filing notes that the Board added one of his two recommended board candidates, Matt McBrady (former Axon/TASER director), but declined the second candidate. Ganz supports the Board's proposed slate for the upcoming shareholders meeting, though he expressed disappointment that the second candidate was not included.

• · No transactions in Common Stock by reporting persons since July 28, 2026 filing.
• · Mr. Ganz retired as CEO on March 2, 2026 and served as consultant for 30 days thereafter.
• · Mr. Ganz's principal occupation is now founder and majority shareholder of NEIP.
• · Matt McBrady was a director of Axon from 2001 to 2014 and again from late 2016 through early 2026.
• · Axon's sales grew from ~$200M in 2017 to >$3.2B (15-fold) and stock appreciated 25-fold during McBrady's second board stint.
• · Ganz supports the Board's proposed slate for the upcoming shareholders meeting per his amended employment agreement.
• · The second recommended candidate was not added to the board; Ganz hopes the board will reconsider.
• · All stock options held by Mr. Ganz are out-of-the-money as of filing date.

08-09-2026

BlackRock Portfolio Management LLC disclosed a 36.4% beneficial ownership stake in Calamos Strategic Total Return Fund's Series H Mandatory Redeemable Preferred Shares, representing 2,200,000 shares out of 6,040,000 outstanding. The filing is a routine Schedule 13G under Rule 13d-1(b), indicating passive investment intent, and includes a power of attorney and disclosure that certain other entities (The Guardian Life Insurance Company of America, The Guardian Insurance & Annuity Company, Inc., and Midland National Life Insurance Company) each hold more than 5% of the shares.

• · The filing is a Schedule 13G, indicating passive investment intent (not for changing or influencing control).
• · The reporting person is organized under Delaware law.
• · The business address of BlackRock Portfolio Management LLC is 50 Hudson Yards, New York, NY 10001.
• · The filing includes a power of attorney dated July 1, 2025, revoking a prior power of attorney dated January 28, 2025.
• · Exhibit 99.1 identifies BlackRock Financial Management, Inc. and HPS Investment Partners, LLC as entities that beneficially own 5% or more of the security class.

08-09-2026

Newlinks Technology Ltd and its affiliates disclosed beneficial ownership of 40,754,920,572 Class A ordinary shares (51.9% of total ordinary shares) and 53.6% voting power (excluding Class D shares) in NaaS Technology Inc. as of August 31, 2026. Including 16,000,000 non-convertible Class D shares held through Envision, Newlinks' total voting power rises to 57.7%. The filing details a multi-class share structure with Class B (10 votes), Class C (2 votes), and Class D (500 votes) shares, and notes that voting control of Class B shares is held by Zhen Dai, while Class C voting is allocated proportionally among other Newlinks shareholders.

• · The filing is an amendment (SC 13D/A) filed on September 8, 2026, with an event date of August 31, 2026.
• · Newlinks' beneficial ownership includes shares held directly and through wholly-owned subsidiaries Envision, Linkage (84.31% owned), and Digital.
• · Class B and Class C shares are convertible into Class A shares at any time; Class D shares are non-convertible.
• · Class A shares carry 1 vote, Class B 10 votes, Class C 2 votes, and Class D 500 votes per share.
• · Voting power of Class B shares is controlled by Zhen Dai; Class C voting power is allocated proportionally among Newlinks shareholders other than Zhen Dai.
• · The filing excludes certain shares from the total outstanding count: ADSs reserved for future issuances, convertible notes to LMR, shares under a Share Subscription Facility Agreement, and warrants to LMR.
• · Principal beneficial owners of Newlinks (over 5%) include Zhen Dai, entities affiliated with Joy Capital, and BCPE Nutcracker Cayman, L.P.

08-09-2026

InnoCare Pharma Inc. and its affiliates disclosed a 10.4% beneficial ownership stake in Zenas BioPharma, Inc. as of August 26, 2026, holding 7,000,000 shares of common stock. The filing is an amendment to a previous Schedule 13G and notes that 2,000,000 of these shares were issued in a private placement that closed on August 31, 2026, upon achievement of a milestone. The reporting persons disclaim group status and state the shares were not acquired to change or influence control.

• · The filing is an amendment (Schedule 13G/A) filed on September 8, 2026, with a date of change of August 26, 2026.
• · InnoCare Pharma Inc. directly holds the 7,000,000 shares; it is a wholly owned subsidiary of Ocean Prominent Limited, which is a wholly owned subsidiary of InnoCare Pharma Limited.
• · The ownership percentage is based on 65,176,723 shares outstanding as of July 31, 2026, plus 2,000,000 shares issued to InnoCare in a private placement closing August 31, 2026.
• · The reporting persons certify the shares were not acquired to change or influence control of the issuer.

08-09-2026

WBT Value Ltd, along with its parent entities Lucky Season Limited, Lucky Season Trust, and portfolio manager Jiezhong Luo, filed a Schedule 13G disclosing beneficial ownership of 5,508,607 Subordinate Voting Shares of Canada Goose Holdings Inc., representing 11.81% of the 46,657,078 shares outstanding as of July 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(c), indicating the shares were not acquired to influence control of the issuer.

• · The filing is made under Rule 13d-1(c), confirming a passive investment intent.
• · The beneficial ownership chain: WBT Value Ltd → wholly owned by Lucky Season Limited → wholly owned by Lucky Season Trust → controlled by Jiezhong Luo.
• · The Reporting Persons' business address is in Hong Kong.
• · A Joint Filing Agreement was executed on September 8, 2026, among all Reporting Persons.

08-09-2026

Eric Li (Shufu Li) and affiliated entities filed Amendment No. 16 to Schedule 13D, disclosing aggregate beneficial ownership of 60.5% of Polestar Automotive Holding UK PLC's Class A ADS and Ordinary Shares as of September 3, 2026. The filing details holdings by Zhejiang Geely Holding Group (39.8%), PSD entities (20.7%), and Volvo Car Corporation (19.9%), among others, with no changes in ownership percentages from prior filings.

• · Filing is Amendment No. 16 to Schedule 13D, originally filed September 3, 2026.
• · Eric Li holds sole voting and dispositive power over 99,358,168 shares.
• · No changes in ownership percentages were reported compared to prior filings.
• · The filing includes signatures from multiple directors and authorized signatories across the Geely and Volvo entities.

08-09-2026

Wellington Management Group LLP and its affiliates filed a Schedule 13G/A with the SEC disclosing beneficial ownership of 8,587,370 shares of AAON, Inc. common stock, representing 10.4% of the outstanding shares as of August 31, 2026. The filing is an amendment to a previous Schedule 13G and indicates the shares are held in the ordinary course of business for investment purposes, not to influence control of the company.

• · The filing is an amendment (13G/A) to a prior Schedule 13G, indicating a change in ownership or filing status.
• · Wellington Management Company LLP, the investment adviser, holds sole voting power over 6,662,742 shares and sole dispositive power over 7,321,511 shares, representing 8.9% of the class.
• · The shares are held for the benefit of clients of various Wellington investment advisers, with no single client owning more than 5% of the class.
• · The filing is made pursuant to Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not to influence control.
• · The joint filing agreement includes Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP.

08-09-2026

Wellington Management Group LLP and its affiliates filed a Schedule 13G/A with the SEC on September 8, 2026, disclosing beneficial ownership of 17,920,770 shares of TPG Inc. common stock, representing 11.2% of the outstanding shares as of August 31, 2026. This filing is an amendment to a previous 13G filing and reflects a passive investment position, with Wellington certifying the shares were not acquired to change or influence control of TPG Inc.

• · The filing is an amendment (SCHEDULE 13G/A) to a previous Schedule 13G.
• · Wellington Management Company LLP directly holds 16,502,180 shares (10.3% of class) as an investment adviser.
• · The shares are owned of record by clients of various Wellington investment advisers, with no single client known to hold more than 5% of the class.
• · The filing includes a joint filing agreement among the Wellington entities.
• · Wellington Management Group LLP is a Massachusetts entity; its subsidiaries are Delaware entities.

08-09-2026

Andy Chang Liu, Chairman and CEO of 17 Education & Technology Group Inc., filed an amended Schedule 13D disclosing that through his affiliated entities (Fluency Holding Ltd. and Future Glory Technology Holdings Limited) he beneficially owns 223,905,836 ordinary shares, representing 41.3% of the outstanding ordinary shares and 95.0% of the total voting power. Between June 30 and September 3, 2026, Future Glory Technology Holdings Limited purchased 110,628 ADSs (representing 5,531,400 Class A ordinary shares) in the open market for approximately $0.24 million under a Rule 10b5-1 trading plan. The filing confirms Liu's continued dominant control over the company, with no change in his overall beneficial ownership percentage or voting power from prior filings.

• · The Rule 10b5-1 trading plan was adopted on March 31, 2026, and authorizes purchases from June 30, 2026 to March 31, 2028.
• · An aggregate of 6,611,302 Class B ordinary shares held by Fluency Holding Ltd. and 18,252,336 Class A ordinary shares and 141,546,832 Class B ordinary shares held by Future Glory Technology Holdings Limited have been pledged as collateral for certain secured loans.
• · Class B ordinary shares carry 30 votes per share, while Class A ordinary shares carry 1 vote per share.
• · The filing is an amendment to the original Schedule 13D filed on November 15, 2024, and Amendment No. 1 filed on August 15, 2025.

08-09-2026

Frontier Nuclear & Minerals Inc. filed a Schedule 13G reporting beneficial ownership of 1,312,451 common shares of Nuran Wireless Inc., representing a 9.9% stake as of June 30, 2026. The position includes 1,259,515 shares directly held and 52,936 shares issuable upon partial exercise of warrants, subject to a 9.99% ownership limitation. The filing is a routine disclosure of a major shareholding.

08-09-2026

T. Rowe Price Associates, Inc. filed an amended Schedule 13G with the SEC, disclosing beneficial ownership of 8,873,588 shares of Kymera Therapeutics, Inc. common stock as of August 31, 2026, representing a 10.7% stake. The filing indicates T. Rowe Price acquired the shares in the ordinary course of business and disclaims beneficial ownership. The stake reflects a significant passive holding by a major institutional investor.

• · T. Rowe Price holds 10.7% of Kymera's outstanding common stock as of August 31, 2026.
• · The filing is an amendment (Schedule 13G/A) under Rule 13d-1(b), indicating passive investment intent.
• · T. Rowe Price expressly disclaims beneficial ownership of the reported securities.
• · The filing was signed by Ellen York, Vice President of T. Rowe Price Associates, Inc.

08-09-2026

T. Rowe Price Associates, Inc. filed an amended Schedule 13G disclosing beneficial ownership of 3,940,556 shares of Midera Food Processing, Inc. (formerly Middleby Food Processing, Inc.) common stock, representing 8.7% of the class as of August 31, 2026. The filing indicates the shares were acquired and are held in the ordinary course of business, not for changing or influencing control. T. Rowe Price expressly denies beneficial ownership of the securities.

• · The filing is an amendment to Schedule 13G, filed under Rule 13d-1(b).
• · T. Rowe Price has sole voting power over 3,924,151 shares and sole dispositive power over 3,940,556 shares.
• · The issuer changed its name from Middleby Food Processing, Inc. to Midera Food Processing, Inc. on September 25, 2025.
• · T. Rowe Price states that not more than 5% of the class is owned by any one client subject to its investment advice.
• · The filing certifies that the securities were not acquired for the purpose of changing or influencing control of the issuer.

08-09-2026

T. Rowe Price Associates, Inc. filed a Schedule 13G with the SEC on September 8, 2026, disclosing beneficial ownership of 14,044,020 shares of 10x Genomics, Inc. Class A common stock as of August 31, 2026, representing an 11.7% stake. The filing indicates that T. Rowe Price acquired and holds the shares in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

• · T. Rowe Price disclaims beneficial ownership of the securities, stating the filing shall not be construed as an admission that it is the beneficial owner.
• · The filing is made under Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control.
• · T. Rowe Price has sole voting power over 13,511,751 shares and sole dispositive power over 14,044,020 shares.

08-09-2026

T. Rowe Price Associates, Inc. filed a Schedule 13G/A with the SEC on September 8, 2026, disclosing beneficial ownership of 4,384,882 shares of Vicor Corp common stock, representing 12.8% of the outstanding shares. The filing indicates a decrease in T. Rowe Price's stake compared to the prior period, as the number of shares reported dropped from 4,167,806 to 4,384,882 (though the prior filing's percentage is not provided). The shares are held in the ordinary course of business and not for changing or influencing control of Vicor Corp.

• · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
• · T. Rowe Price Associates, Inc. expressly denies being the beneficial owner of the securities, stating the filing shall not be construed as an admission of beneficial ownership.
• · The shares were acquired and are held in the ordinary course of business, not for changing or influencing control of Vicor Corp.
• · The filing is made under Rule 13d-1(b), indicating the filer is an institutional investment manager.

08-09-2026

T. Rowe Price Associates, Inc. filed an amended Schedule 13G with the SEC on September 8, 2026, reporting beneficial ownership of 231,010 common shares of Perrigo Co plc, representing 0.1% of the company's outstanding shares as of August 31, 2026. The filing is a routine disclosure under Rule 13d-1(b) and does not indicate any change in control intent.

• · The filing is an amendment (13G/A) to a previously filed Schedule 13G.
• · T. Rowe Price Associates, Inc. is an investment adviser filing under Rule 13d-1(b).
• · The shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Perrigo.
• · T. Rowe Price Associates, Inc. expressly denies beneficial ownership of the securities.

08-09-2026

T. Rowe Price Associates, Inc. filed an amended Schedule 13G with the SEC on September 8, 2026, disclosing beneficial ownership of 83,947,933 ADRs of iQIYI, Inc., representing 8.8% of the company's outstanding shares. The filing indicates a slight decrease in holdings from the prior reported 83,350,459 ADRs (an increase of 597,474 ADRs), and the stake remains below the 10% threshold. The filing is a routine disclosure of passive investment and does not indicate any change in control intent.

• · T. Rowe Price Associates, Inc. is an investment adviser (IA) filing under Rule 13d-1(b).
• · The filing is an amendment (13G/A) to a previously filed Schedule 13G.
• · The beneficial ownership is held in the ordinary course of business, with no intent to change or influence control of iQIYI.
• · T. Rowe Price expressly denies beneficial ownership of the securities for purposes of the filing.
• · The filing was signed on September 8, 2026, by Ellen York, Vice President.

08-09-2026

FMR LLC (Fidelity) filed a Schedule 13G/A with the SEC disclosing a 0.0% beneficial ownership stake in Leggett & Platt Inc as of August 31, 2026, holding only 117 shares. This filing represents a material reduction from any prior reported position, indicating that Fidelity has effectively exited its investment in the company.

• · FMR LLC reported sole voting power over 0 shares and sole dispositive power over 0 shares.
• · The filing indicates that no other person's interest in the common stock exceeds 5% of the total outstanding shares.
• · Abigail P. Johnson individually reported the same 117 shares with 0.0% ownership.
• · The beneficial ownership percentage is 0.0% (fractional percentage) based on the filing's cover page.

08-09-2026

FMR LLC filed an amended Schedule 13G with the SEC on September 8, 2026, reporting beneficial ownership of 695.53 shares of iShares MSCI UAE ETF common stock as of August 31, 2026, representing 0.0% of the outstanding shares. The filing is a routine disclosure of passive investment holdings and includes a joint filing agreement under Rule 13d-1(k)(1).

• · Filing date: September 8, 2026
• · Beneficial ownership date: August 31, 2026
• · FMR LLC is a Delaware corporation with principal offices at 245 Summer Street, Boston, MA 02210
• · Abigail P. Johnson is the Chairman and CEO of FMR LLC; Johnson family members hold 49% of voting power of FMR LLC through Series B voting common shares
• · Joint filing agreement under Rule 13d-1(k)(1) executed on September 4, 2026

08-09-2026

FMR LLC (Fidelity) disclosed a 12.7% beneficial ownership stake in Onterris, Inc. (formerly Montrose Environmental Group, Inc.) as of August 31, 2026, holding 4,461,078 shares of common stock. The filing is a routine Schedule 13G by a passive institutional investor, indicating the stake was acquired in the ordinary course of business and not to influence control. Notably, Fidelity Value Fund alone held 2,311,528 shares, representing 6.6% of the outstanding common stock.

• · The filing is made under Rule 13d-1(b), confirming passive investor status.
• · FMR LLC's address is 245 Summer Street, Boston, Massachusetts 02210.
• · Abigail P. Johnson is the Chairman and CEO of FMR LLC; the Johnson family holds 49% of the voting power of FMR LLC through Series B voting common shares.
• · A shareholders' voting agreement among Series B shareholders means all Series B shares are voted in accordance with the majority vote of Series B shares.
• · The filing includes a Rule 13d-1(k)(1) joint filing agreement between FMR LLC and Abigail P. Johnson.

08-09-2026

FMR LLC filed an amended Schedule 13G with the SEC on September 8, 2026, disclosing beneficial ownership of 4,865,628.13 shares of Charles River Laboratories International, Inc. common stock as of August 31, 2026, representing 10.2% of the outstanding shares. The filing indicates the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. This is a routine disclosure of a significant passive stake, with no change in control or strategic intent indicated.

• · FMR LLC's beneficial ownership is 10.2% of Charles River Laboratories' outstanding common stock.
• · The filing is an amendment to Schedule 13G, indicating a passive investment intent.
• · The filing was made pursuant to Rule 13d-1(b), confirming the shares are not held with the purpose of changing or influencing control.
• · The filing includes a joint filing agreement under Rule 13d-1(k)(1) among FMR LLC and Abigail P. Johnson.
• · The filing reflects securities beneficially owned by FMR LLC and certain subsidiaries and affiliates, but excludes securities of certain other companies disaggregated per SEC Release No. 34-39538.

08-09-2026

FMR LLC filed an amended Schedule 13G with the SEC, disclosing beneficial ownership of 1,783,202.25 shares of LENZ Therapeutics, Inc. common stock, representing 5.7% of the outstanding shares as of August 31, 2026. The filing indicates the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. This is a routine disclosure of a major shareholder's holdings and does not indicate any change in control or investment strategy.

• · FMR LLC's beneficial ownership is 1,783,202.25 shares, representing 5.7% of LENZ Therapeutics' outstanding common stock as of August 31, 2026.
• · The filing is an amendment (SC 13G/A) to a previous Schedule 13G, indicating an update to the reported holdings.
• · The filing is made under Rule 13d-1(b), indicating the shares are held in the ordinary course of business and not with the purpose of changing or influencing control.
• · The filing includes a joint filing agreement under Rule 13d-1(k)(1) between FMR LLC and Abigail P. Johnson.
• · The filing does not reflect securities beneficially owned by certain other companies whose ownership is disaggregated from the FMR Reporters.

08-09-2026

FMR LLC (Fidelity) filed a Schedule 13G/A disclosing beneficial ownership of 126,764,446.45 shares of Viatris Inc common stock as of August 31, 2026, representing an 11.0% stake. The filing is an amendment to a previous 13G and reflects Fidelity's continued significant passive investment in Viatris. No prior period comparison is available in this filing to assess changes in ownership.

• · FMR LLC has sole voting power over $113,359,609.44 of the reported shares.
• · FMR LLC has sole dispositive power over the entire $126,764,446.45 stake.
• · The filing is made pursuant to Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not to change or influence control of Viatris.
• · Abigail P. Johnson, through family ownership and a voting agreement, may be deemed to form a controlling group with respect to FMR LLC.
• · Fidelity Management & Research Company LLC is an entity that beneficially owns 5% or greater of the reported security class.

08-09-2026

FMR LLC filed an amended Schedule 13G with the SEC disclosing beneficial ownership of 16,709,843.48 common shares (12.0%) of the State Street SPDR Nuveen ICE High Yield Municipal Bond ETF as of August 31, 2026. The filing was made pursuant to Rule 13d-1(b) and indicates the securities were acquired and are held in the ordinary course of business, not for control purposes. No period-over-period comparison data is available to assess whether FMR’s stake increased or decreased from prior filings.

• · The filing is an amendment (SC 13G/A) to a previously filed Schedule 13G.
• · FMR LLC is incorporated in Delaware with principal business address at 245 Summer Street, Boston, MA 02210.
• · The filer certifies that the securities were acquired in the ordinary course of business and not for control purposes.
• · Strategic Advisers LLC is identified as a relevant entity that beneficially owns 5% or greater of the outstanding shares.
• · Abigail P. Johnson, as part of the Johnson family, may be deemed to form a controlling group with respect to FMR LLC under the Investment Company Act of 1940.
• · The filing includes a Rule 13d-1(k)(1) joint filing agreement between FMR LLC and Abigail P. Johnson.

08-09-2026

FMR LLC (parent of Fidelity Investments) filed an amended Schedule 13G with the SEC on September 8, 2026, reporting that as of August 31, 2026, it beneficially owned 0 shares of Orla Mining Ltd. common stock, representing 0.0% of the outstanding shares. This represents a complete exit from its previous position, as the filing shows zero beneficial ownership across all categories for both FMR LLC and its CEO Abigail P. Johnson.

• · Filing date: September 8, 2026; beneficial ownership as of August 31, 2026.
• · FMR LLC is a Delaware corporation with business address at 245 Summer Street, Boston, MA 02210.
• · Abigail P. Johnson, as Director, Chairman and CEO of FMR LLC, also reported 0 shares and 0.0% beneficial ownership.
• · The filing is made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · The Johnson family holds 49% of the voting power of FMR LLC through Series B voting common shares and a shareholders' voting agreement.

08-09-2026

FMR LLC (Fidelity) disclosed beneficial ownership of 31,516,672.50 shares of Graphic Packaging Holding Co common stock as of August 31, 2026, representing a 10.6% stake. The filing is an amendment to Schedule 13G, indicating passive investment intent, and includes joint filer Abigail P. Johnson. No prior period comparison is available in this filing, so no period-over-period changes can be assessed.

• · FMR LLC's beneficial ownership includes shares held by subsidiaries FIAM LLC, Fidelity Institutional Asset Management Trust Company, Fidelity Management & Research Company LLC, Fidelity Management Trust Company, and Strategic Advisers LLC.
• · Abigail P. Johnson is a Director, Chairman, and CEO of FMR LLC, and members of the Johnson family hold 49% of the voting power of FMR LLC through Series B voting common shares.
• · The filing is made pursuant to Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not to change or influence control.
• · No single other person holds more than 5% of the outstanding common stock of Graphic Packaging Holding Co.

08-09-2026

FMR LLC (Fidelity) disclosed a 10.6% beneficial ownership stake in ADI Global Distribution Inc. as of August 31, 2026, holding 8,029,560.22 shares of common stock. The filing was made under Rule 13d-1(b) as a passive investment, indicating Fidelity does not intend to influence control of the company. Abigail P. Johnson, Chairman and CEO of FMR LLC, is also reported as a beneficial owner with the same number of shares.

• · The filing is a Schedule 13G, indicating passive investment intent under Rule 13d-1(b).
• · FMR LLC has sole voting power over 8,021,446 shares and sole dispositive power over 8,029,560.22 shares.
• · Abigail P. Johnson is deemed to beneficially own the same 8,029,560.22 shares (10.6%) through her position and family voting agreement.
• · The Johnson family holds 49% of the voting power of FMR LLC through Series B voting common shares and a shareholders' voting agreement.
• · FMR LLC and certain subsidiaries (FIAM LLC, Fidelity Management & Research Company LLC, etc.) are included in the filing; some entities' holdings are disaggregated per SEC Release No. 34-39538.

08-09-2026

FMR LLC (parent of Fidelity) disclosed a 10.9% beneficial ownership stake in SunocoCorp LLC as of August 31, 2026, holding 5,632,345 common shares. The filing is an amendment to Schedule 13G, indicating the stake is held in the ordinary course of business and not for control purposes. Abigail P. Johnson, Chairman and CEO of FMR LLC, is also reported as a beneficial owner of the same number of shares.

• · The filing is an amendment (Schedule 13G/A) filed on September 8, 2026, with a date of change of September 8, 2026.
• · FMR LLC qualifies under Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not to influence control.
• · Abigail P. Johnson is also reported as a beneficial owner of the same 5,632,345 shares (10.9%), classified as 'IN' (individual).
• · No single other person's interest in the common stock exceeds 5% of the total outstanding shares.
• · The filing includes a joint filing agreement under Rule 13d-1(k)(1) among FMR LLC and Abigail P. Johnson.

08-09-2026

FMR LLC (Fidelity) filed an amended Schedule 13G with the SEC disclosing beneficial ownership of 514,925 shares of Tenax Therapeutics common stock as of August 31, 2026, representing 1.4% of the outstanding shares. The filing is a routine update under Rule 13d-1(b) and indicates Fidelity's holdings are held in the ordinary course of business, not for control purposes.

• · Filing is an amendment (SC 13G/A) to a previous Schedule 13G.
• · FMR LLC's sole voting power is 514,450 shares; shared voting power is 0.
• · Abigail P. Johnson individually holds 0 shares directly but may be deemed to beneficially own the same 514,925 shares through her control of FMR LLC.
• · No single person other than FMR LLC is known to have an interest in more than 5% of the outstanding common stock.
• · The filing includes a joint filing agreement under Rule 13d-1(k)(1).

08-09-2026

FMR LLC (Fidelity) disclosed a 13.2% beneficial ownership stake in Twist Bioscience Corp as of August 31, 2026, holding 8,760,081.45 shares of common stock. This filing is an amendment to a previous Schedule 13G and reflects Fidelity's passive investment in the company, with no intent to change or influence control.

• · FMR LLC's sole voting power is 8,755,210.44 shares, slightly less than its total beneficial ownership of 8,760,081.45 shares.
• · The filing is made under Rule 13d-1(b), indicating passive investment intent.
• · Abigail P. Johnson, through family ownership and a voting agreement, may be deemed to form a controlling group with respect to FMR LLC.
• · Fidelity Management & Research Company LLC beneficially owns 5% or greater of the outstanding shares.

08-09-2026

FMR LLC (Fidelity) disclosed a 4.1% beneficial ownership stake in Bowman Consulting Group Ltd. as of August 31, 2026, holding 704,096 shares of common stock. The filing is an amendment to Schedule 13G, indicating the shares were acquired in the ordinary course of business and not for changing or influencing control. Abigail P. Johnson, Chairman and CEO of FMR LLC, is also reported as a beneficial owner of the same number of shares.

• · The filing is an amendment to Schedule 13G, filed under Rule 13d-1(b).
• · FMR LLC's sole voting power is 704,042 shares; sole dispositive power is 704,096 shares.
• · Abigail P. Johnson is deemed to beneficially own 704,096 shares (4.1%) through her role and family ownership of FMR LLC voting shares.
• · The Johnson family holds 49% of the voting power of FMR LLC through Series B voting common shares and a shareholders' voting agreement.
• · No single person other than the reporting persons has an interest in more than 5% of the outstanding common stock.

08-09-2026

FMR LLC (Fidelity) filed an amended Schedule 13G with the SEC disclosing beneficial ownership of 16,715,889.74 common shares of Resideo Technologies, Inc. as of August 31, 2026, representing 11.0% of the outstanding shares. The filing is a routine institutional ownership disclosure and does not indicate any change in control intent.

• · Filing date: September 8, 2026. Reporting date of ownership: August 31, 2026.
• · Abigail P. Johnson is the Chairman and CEO of FMR LLC and also reports beneficial ownership of the same 16,715,889.74 shares (11.0%).
• · The filing is made under Rule 13d-1(b) indicating the shares were acquired in the ordinary course of business and not with the purpose of changing control.
• · FMR LLC is a Delaware corporation with business address at 245 Summer Street, Boston, MA 02210.
• · Multiple subsidiaries of FMR LLC are listed as entities that beneficially own shares, including Fidelity Management & Research Company LLC which beneficially owns 5% or greater.

08-09-2026

FMR LLC filed a Schedule 13G disclosing beneficial ownership of 613,582.84 shares (14.1%) of the Avantis Responsible International Equity ETF, a series of American Century ETF Trust, as of August 31, 2026. The filing indicates the shares are held in the ordinary course of business and not for control purposes. No changes in ownership were reported for the period.

• · Filing date: September 8, 2026; ownership as of August 31, 2026.
• · FMR LLC is the parent entity; Strategic Advisers LLC is an investment adviser and beneficially owns 5% or more.
• · Abigail P. Johnson and the Johnson family control FMR LLC through Series B voting shares and a voting agreement.
• · The filing is a joint filing under Rule 13d-1(k)(1) agreement dated September 4, 2026.

08-09-2026

FMR LLC (Fidelity) disclosed a 10.2% beneficial ownership stake in Blue Bird Corp as of August 31, 2026, holding 3,218,919 shares of common stock. The filing is an amendment to Schedule 13G, indicating the stake was acquired in the ordinary course of business and not for control purposes. No prior-period comparison is available in this filing, so no period-over-period changes can be assessed.

• · FMR LLC's beneficial ownership includes shares held by subsidiaries FIAM LLC, Fidelity Institutional Asset Management Trust Company, Fidelity Management & Research Company LLC, and Strategic Advisers LLC.
• · Abigail P. Johnson and the Johnson family hold 49% of the voting power of FMR LLC through Series B voting common shares and a shareholders' voting agreement.
• · The filing is made pursuant to Rule 13d-1(b) and includes a joint filing agreement among the reporting persons.

08-09-2026

FMR LLC (Fidelity) filed an amended Schedule 13G with the SEC on September 8, 2026, reporting beneficial ownership of 1,083,054 common shares of Luxfer Holdings PLC as of August 31, 2026, representing 3.7% of the outstanding shares. The filing is a routine disclosure under Rule 13d-1(b) and indicates no change in control intent. No prior period comparison is available in this filing, so no period-over-period analysis is possible.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b), indicating passive investment intent.
• · FMR LLC's beneficial ownership includes shares held by Fidelity Management & Research Company LLC (an investment adviser).
• · Abigail P. Johnson and the Johnson family are the predominant owners of FMR LLC's Series B voting common shares, representing 49% of voting power.
• · No single person other than the reporting entities has an interest of more than 5% in the common stock.
• · The filing includes a joint filing agreement under Rule 13d-1(k)(1) between FMR LLC and Abigail P. Johnson.

08-09-2026

FMR LLC filed a Schedule 13G/A disclosing beneficial ownership of 3,553,635 shares of Covista Inc. (formerly Adtalem Global Education Inc.) common stock, representing 10.4% of the outstanding shares as of August 31, 2026. The filing is an amendment to a prior Schedule 13G, indicating a passive investment position. No change in control intent is stated.

• · FMR LLC's beneficial ownership is 3,553,635 shares, representing 10.4% of Covista Inc.'s outstanding common stock.
• · The filing is made pursuant to Rule 13d-1(b), indicating passive investment intent.
• · Fidelity Management & Research Company LLC is the only entity listed that beneficially owns 5% or more of the outstanding shares.
• · The filing includes a joint filing agreement under Rule 13d-1(k)(1).
• · Covista Inc. was formerly known as Adtalem Global Education Inc., with a name change effective May 24, 2017.

08-09-2026

1832 Asset Management L.P. filed a Schedule 13G/A with the SEC on September 8, 2026, disclosing beneficial ownership of 2,926,264 common shares of Boyd Group Services Inc., representing 10.5% of the outstanding shares. The filing also includes holdings by MD Financial Management Inc. (42,838 shares, 0.2%) and Scotia Capital Inc. (29,730 shares, 0.1%), with the aggregate beneficial ownership totaling 2,998,832 shares (10.77%). This passive investment filing indicates no change in control intent.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b), indicating passive investment intent.
• · 1832 Asset Management L.P. is a Canadian investment adviser and broker dealer.
• · The filing certifies that securities were acquired in the ordinary course of business and not to change or influence control of the issuer.
• · The filing date is September 8, 2026, with the event date as of August 31, 2026.

08-09-2026

Thomas John Corley filed a Schedule 13G/A with the SEC on September 8, 2026, disclosing beneficial ownership of 540,000 shares of SOBR Safe, Inc. common stock, representing 10.0% of the 5,387,210 shares outstanding as of August 13, 2026. The filing indicates no change in ownership from the prior filing, with the same 540,000 shares and 10.0% stake reported.

• · The filing is an amendment (13G/A) to a previously filed Schedule 13G.
• · Thomas John Corley has sole voting and dispositive power over all 540,000 shares.
• · The shares were acquired and are held for investment purposes only, not to change or influence control of the issuer.
• · The filing was made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.

08-09-2026

Al Shams Investments Ltd, the largest shareholder of Braemar Hotels & Resorts Inc. (BHR), filed an amended Schedule 13D on September 8, 2026, announcing its intention to nominate a full slate of five independent directors to the Board at the 2026 Annual Meeting. The move follows the Company's announcement of a September 14 nomination deadline, which Al Shams criticizes as a compressed window designed to hinder shareholder participation. Al Shams and Wafic Rida Said collectively own 6,513,000 shares (9.48% of the Company), and they plan to file a definitive proxy statement to solicit proxies for their nominees.

• · Al Shams is the largest shareholder of Braemar Hotels & Resorts.
• · The nomination deadline is September 14, 2026.
• · Al Shams plans to nominate five director nominees.
• · The Company's 2026 Annual Meeting date was announced on September 4, 2026.
• · Al Shams criticizes the Company's governance practices, including the compressed nomination window and external management structure.
• · The proxy statement will be filed on Schedule 14A with a WHITE Universal Proxy Card.

08-09-2026

MetLife Investment Management, LLC filed an amended Schedule 13G/A with the SEC on September 8, 2026, disclosing that as of August 31, 2026, it beneficially owns 0 Series D Mandatory Redeemable Preferred Shares of Calamos Dynamic Convertible & Income Fund, representing 0% of that class. The filing indicates no change in ownership and is made under Rule 13d-1(b), with the reporting person certifying the shares were acquired in the ordinary course of business and not for control purposes.

• · Filing is an amendment (13G/A) to a prior Schedule 13G.
• · The reporting person is MetLife Investment Management, LLC, a Delaware LLC, with principal office at One MetLife Way, Whippany, NJ.
• · The filing is made pursuant to Rule 13d-1(b), indicating passive investment intent.
• · The certification confirms the securities were not acquired to change or influence control of the issuer.

08-09-2026

Libra Advisors LLC and related entities (Ranjan Tandon, LLC, Libra Fund, L.P., Krishnamurthy Tandon Foundation Inc., and Ranjan Tandon) filed a Schedule 13G with the SEC on September 8, 2026, disclosing beneficial ownership of 64,103,827 common shares of i-80 Gold Corp., representing 7.44% of the 861,071,221 shares outstanding as of June 30, 2026. The filing indicates passive investment intent under Rule 13d-1(c), with no purpose of changing or influencing control of the issuer.

• · The filing was made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, indicating a passive investment.
• · The reporting persons disclaim beneficial ownership of securities held by other entities except to the extent of their pecuniary interest.
• · Various individuals beyond the reporting persons may have the right to receive dividends or proceeds from sales, but none relate to more than 5% of the class.

08-09-2026

ATG Capital Opportunities Fund LP and related reporting persons disclosed beneficial ownership of 4,500,000 shares (16.0%) of Empery Digital Inc. in an amended Schedule 13D filed September 8, 2026. The filing also reveals that on September 4, 2026, ATG Fund withdrew its nominations of five individuals for election to the Board and instead filed a definitive proxy statement to elect Gabriel D. Gliksberg, James C. Elbaor, Meredith S. Kirshenbaum, and Aaron T. Morris. No new transactions in the issuer's securities occurred since the prior amendment.

• · The filing is Amendment No. 8 to the Schedule 13D originally filed on January 26, 2026.
• · The withdrawn nominees (Batta, Davies, Novak, Ratner, Powers) are no longer parties to the Joint Filing and Solicitation Agreement (JFSA).
• · The remaining reporting persons and the four new nominees remain party to the JFSA.
• · No transactions in the issuer's securities were reported by the reporting persons since Amendment No. 7.

08-09-2026

MetLife Investment Management, LLC disclosed beneficial ownership of 290,000 Series H Mandatory Redeemable Preferred Shares of CALAMOS CONVERTIBLE & HIGH INCOME FUND (CHY), representing 50% of the 580,000 outstanding shares in that series, as of August 31, 2026. The shares are held on behalf of clients including Metropolitan Life Insurance Company and Metropolitan Tower Life Insurance Company. The filing is a routine Schedule 13G under Rule 13d-1(b), indicating passive investment intent with no control-related purpose.

• · The filing is made under Rule 13d-1(b), confirming passive investment intent.
• · MetLife Investment Management holds the shares on behalf of multiple clients, including Metropolitan Life Insurance Company and Metropolitan Tower Life Insurance Company.
• · The beneficial owner has sole voting power and sole dispositive power over all 290,000 shares.
• · No other person is reported as having shared voting or dispositive power.

08-09-2026

MetLife Investment Management, LLC disclosed beneficial ownership of 440,000 Series H Mandatory Redeemable Preferred Shares of Calamos Global Dynamic Income Fund (CHW), representing approximately 38.6% of the class, as of August 31, 2026. The shares are held on behalf of clients including 21st Century Insurance Company and Metropolitan Life Insurance Company, and the filing is made under Rule 13d-1(b), indicating passive investment intent. No change in ownership or control is reported.

• · Filing type is Schedule 13G (passive investment, not 13D active).
• · MetLife Investment Management is a Delaware limited liability company registered as an investment adviser (IA).
• · The filing date is September 8, 2026, with beneficial ownership as of August 31, 2026.
• · No sole or shared voting power is reported; all 440,000 shares are held with shared dispositive power.
• · The filer certifies the shares were not acquired to change or influence control of the issuer.

08-09-2026

MetLife Investment Management, LLC disclosed beneficial ownership of 345,000 Series H Mandatory Redeemable Preferred Shares of CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND (CHI), representing 50% of the outstanding Series H shares as of August 31, 2026. The shares are managed on behalf of clients including 21St Century Insurance Company, Metropolitan Life Insurance Company, and Metropolitan Tower Life Insurance Company. The filing is made under Rule 13d-1(b) and certifies the shares were acquired in the ordinary course of business without intent to change or influence control.

• · Filing is a Schedule 13G (passive investment, not an activist filing) under Rule 13d-1(b).
• · MetLife Investment Management, LLC is a Delaware limited liability company and an investment adviser.
• · The Reporting Person has sole voting power over 0 shares and sole dispositive power over 345,000 shares.
• · No shares are held by the Reporting Person directly; all 345,000 shares are managed on behalf of clients.